asia healthspace

A few weeks ago I posted a summary of research on the top 10 domestic medical device manufacturers in China. The full report which is far more comprehensive is now ready and can be downloaded from this link below: http://www.clearstate.com/asian-healthcare-titans-2013-medtech-china/ Tej Deol, MD., M.B.A.

China is the world’s most populous country with a population of over 1.35 billion. As of 2013, it also boasts the world’s second-largest economy by both nominal total GDP as well as by purchasing power parity (PPP). The nation is also the world’s largest exporter and importer of goods. In this report Clearstate studies the landscape [...]

Hospital markets country briefs China   We have explored the many trends driving the growth in China’s healthcare market in the above sections. With the recent policy change allowing 100% non-Chinese ownership of hospitals and other health services, foreign and private ventures in China’s healthcare sector is projected to increase over time. In fact, the [...]

Part 3 of the report Asia healthcare Titans 2013 from Clearstate Pte Ltd. Source: More than 10% stake, deal worth more than US$ 15 million, target country Asia. Unless otherwise indicated, source: Bloomberg & EIU Zephyr databases Tej Deol, M.D.

Supply drivers and trends in Asia   Strong demand inadequately met by current infrastructure At 2.08 beds and 1.09 doctors per 1,000 population, Asia and Australasia lags behind the global average (2.72 and 1.72 respectively, refer to Figure 6 below).[i] As Asia continues in its growth trajectory, demand will continue to outstrip supply. The market [...]

Demand drivers and trends in Asia GDP growth drives healthcare spending   With real GDP growth rates almost double the global average (5.70% compared to 2.30%[i]), Asia will be a prime driver of global economic growth going forward. At real GDP growth in the range of 5–8% in Asia annually, and with healthcare projected to [...]

The following series of posts describing the current landscape in the Hospital sector in prominent Asia Pacific markets are derived from a proprietary report developed by Clearstate. Clearstate, an Economist Intelligence Unit healthcare business, is the market leader in healthcare research-based consulting in the emerging markets. The analysis and content in this report is derived [...]

Struggle to combat infectious diseases while manage rapid growth of chronic diseases in India: Significant economic burden with estimated 50 million diabetics and high mortality rate due to chronic diseases such as cardiovascular disease India has the second largest population in the world and its GDP is ranked 9th in the world. The healthcare sector [...]

Transition from infectious diseases to rise of chronic diseases, with more than 2.2 Million new cases of cancer annually, and 1 in 5 adults suffering from cardiovascular disease Home to a population of 1.3 billion people, China is now the world’s largest economy after the US. China’s healthcare and disease profiles are undergoing significant changes [...]

Overview Lower limb peripheral artery disease landscape Lower limb peripheral artery disease (PAD) or peripheral vascular disease (PVD) is a cardiovascular disease that leads to narrowing and hardening of arteries found outside the coronary, aortic arch and brain.  With an estimated 10 million people in these markets who are diagnosed with lower limb PAD annually, [...]